{
  "cache_date": "2025-05-01T09:47:01.617383",
  "data": [
    {
      "created": "2025-05-01T06:32:58.256425+00:00",
      "modified": "2025-05-01T06:32:58.502716+00:00",
      "id": 15314652,
      "conceptrecid": "15314651",
      "doi": "10.5281/zenodo.15314652",
      "conceptdoi": "10.5281/zenodo.15314651",
      "doi_url": "https://doi.org/10.5281/zenodo.15314652",
      "metadata": {
        "title": "Brain Tumor Prediction with Machine Learning",
        "doi": "10.5281/zenodo.15314652",
        "publication_date": "2025-05-01",
        "description": "<p><em><span>This<span> </span>review<span> </span>aims<span> </span>to<span> </span>systematically analyze ML models from four aspects: The investigation<span> </span>is<span> </span>based<span> </span>on<span> </span>the<span> </span>nurture<span> </span>of<span> </span>the<span> </span>ML technique, estimation precision, model evolution, and estimation setting. The <span>systematic</span><span> </span><span>literature</span><span> </span><span>review</span><span> </span><span>of</span><span> </span><span>empirical</span><span> </span><span>studies </span>focused<span> </span>on<span> </span>the published<span> </span>articles<span> </span>on<span> </span>ML<span> </span>models of the last decades. From the above sources, fifty-one primary studies concerning the objective of this research were identified on analy</span></em><span>zi<em>ng these studies; five ML techniques have been using it in the classification and prediction of brain tumors. the accuracies achieved by the estimated ML<span> </span>models can<span> </span>be <span>consistories</span><span> </span><span>satisfactory,</span><span> </span><span>as</span><span> </span><span>they</span><span> </span><span>either</span><span> </span><span>match</span><span> </span><span>or </span>surpass those of non-</em>3f<em>L models. The phenomenon of using improved machine learning models to classify and<span> </span>predict brain tumors him been the subject of numerous studies. Accenting to the mutters of the corresponding words, the genetic algorithm achieve&lsaquo;t the highest level of prediction accuracy<span> </span>more<span> </span>than<span> </span>10<span> a</span>mong<span> </span>null<span> </span>the models that were tried. However, because of <span>their</span><span> </span><span>complexity,</span><span> </span><span>these</span><span> </span></em><span>3f<em>L</em></span><em><span> </span><span>models</span><span> </span><span>have</span><span> </span><span>not</span><span> </span><span>yet </span>been adopted by the industry and thus need more development.</em></span></p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Tamirah Sharieff",
            "affiliation": null
          },
          {
            "name": "Zoya Harmain",
            "affiliation": null
          },
          {
            "name": "ShafiyaNoorain",
            "affiliation": null
          },
          {
            "name": "Sarah Smyrline R",
            "affiliation": null
          },
          {
            "name": "Dr.Deepak NR",
            "affiliation": null
          },
          {
            "name": "Om Prakash B",
            "affiliation": null
          }
        ],
        "keywords": [
          "Brain Turner; Machine Learning; Prediction, Medical Imaging; Classification, Neurul Networks; Computer Aided Diagnosis Early Detection"
        ],
        "references": [
          "1.\tAmerican Cancer Society. (2021). Cancer facts & figures 2021.",
          "2.\tChen, J., et al. (2020). Reading the fine print of machine learning for healthcare. IEEE Access.",
          "3.\tClark, K., et al. (2013). The Cancer Imaging Archive (TCIA): The need to run and sustain a public information archive. Journal of Digital Imaging.",
          "4.\tHavaei, M., et al. (2017). Using advances in computer-assisted interventions and medical imaging, Havaei and colleagues investigated the potential of deep learning to enhance prostate cancer detection.",
          "5.\tJiang, R., et al. (2020). Machine learning for brain tumour early detection. Frontiers in Neuroscience.",
          "6.\tKhosravi, P., et al. (2019). Personalized medicine in cancer: Opportunities and challenges. Journal of Personalized Medicine.",
          "7.\tMarcus, D. S., et al. (2007). OASIS: The Open Access Series of Imaging Studies. NeuroImage.",
          "8.\tMenze, B. H., et al. (2015). Multimodal brain tumor image segmentation: The BRATS challenge. IEEE Periodicals on Medical Imaging.",
          "9.\tM\u00fcller, H. W., et al. (2019). Application of PET scan in therapy of brain tumors. Current Treatment Options in Oncology.",
          "10.\tMorris, E. R., et al. (2018). Machine learning in neurology: A paper close to clinical practice. Journal of Neurology."
        ],
        "language": "eng",
        "resource_type": {
          "title": "Journal article",
          "type": "publication",
          "subtype": "article"
        },
        "journal": {
          "issue": "2",
          "pages": "17-24",
          "title": "Journal of Advancement in Parallel Computing",
          "volume": "8"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "communities": [
          {
            "id": "compub"
          }
        ],
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "15314651"
              }
            }
          ]
        }
      },
      "title": "Brain Tumor Prediction with Machine Learning",
      "links": {
        "self": "https://zenodo.org/api/records/15314652",
        "self_html": "https://zenodo.org/records/15314652",
        "preview_html": "https://zenodo.org/records/15314652?preview=1",
        "doi": "https://doi.org/10.5281/zenodo.15314652",
        "self_doi": "https://doi.org/10.5281/zenodo.15314652",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15314652",
        "parent": "https://zenodo.org/api/records/15314651",
        "parent_html": "https://zenodo.org/records/15314651",
        "parent_doi": "https://doi.org/10.5281/zenodo.15314651",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15314651",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:15314652/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:15314652/sequence/default",
        "files": "https://zenodo.org/api/records/15314652/files",
        "media_files": "https://zenodo.org/api/records/15314652/media-files",
        "thumbnails": {
          "10": "https://zenodo.org/api/iiif/record:15314652:BRAIN%20TUMOR%20PREDICTION%20WITH%20MACHINE%20LEARNING%20-Formatted%20Paper.pdf/full/^10,/0/default.jpg",
          "50": "https://zenodo.org/api/iiif/record:15314652:BRAIN%20TUMOR%20PREDICTION%20WITH%20MACHINE%20LEARNING%20-Formatted%20Paper.pdf/full/^50,/0/default.jpg",
          "100": "https://zenodo.org/api/iiif/record:15314652:BRAIN%20TUMOR%20PREDICTION%20WITH%20MACHINE%20LEARNING%20-Formatted%20Paper.pdf/full/^100,/0/default.jpg",
          "250": "https://zenodo.org/api/iiif/record:15314652:BRAIN%20TUMOR%20PREDICTION%20WITH%20MACHINE%20LEARNING%20-Formatted%20Paper.pdf/full/^250,/0/default.jpg",
          "750": "https://zenodo.org/api/iiif/record:15314652:BRAIN%20TUMOR%20PREDICTION%20WITH%20MACHINE%20LEARNING%20-Formatted%20Paper.pdf/full/^750,/0/default.jpg",
          "1200": "https://zenodo.org/api/iiif/record:15314652:BRAIN%20TUMOR%20PREDICTION%20WITH%20MACHINE%20LEARNING%20-Formatted%20Paper.pdf/full/^1200,/0/default.jpg"
        },
        "archive": "https://zenodo.org/api/records/15314652/files-archive",
        "archive_media": "https://zenodo.org/api/records/15314652/media-files-archive",
        "latest": "https://zenodo.org/api/records/15314652/versions/latest",
        "latest_html": "https://zenodo.org/records/15314652/latest",
        "versions": "https://zenodo.org/api/records/15314652/versions",
        "draft": "https://zenodo.org/api/records/15314652/draft",
        "reserve_doi": "https://zenodo.org/api/records/15314652/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/15314652/access/links",
        "access_grants": "https://zenodo.org/api/records/15314652/access/grants",
        "access_users": "https://zenodo.org/api/records/15314652/access/users",
        "access_request": "https://zenodo.org/api/records/15314652/access/request",
        "access": "https://zenodo.org/api/records/15314652/access",
        "communities": "https://zenodo.org/api/records/15314652/communities",
        "communities-suggestions": "https://zenodo.org/api/records/15314652/communities-suggestions",
        "requests": "https://zenodo.org/api/records/15314652/requests"
      },
      "updated": "2025-05-01T06:32:58.502716+00:00",
      "recid": "15314652",
      "revision": 4,
      "files": [
        {
          "id": "c055efac-b13f-4b16-8a19-c3c13e4c08fc",
          "key": "BRAIN TUMOR PREDICTION WITH MACHINE LEARNING -Formatted Paper.pdf",
          "size": 292961,
          "checksum": "md5:1bc0c9c47bb67dc1e8375f922aadad4e",
          "links": {
            "self": "https://zenodo.org/api/records/15314652/files/BRAIN TUMOR PREDICTION WITH MACHINE LEARNING -Formatted Paper.pdf/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "109378"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 0,
        "unique_downloads": 0,
        "views": 1,
        "unique_views": 1,
        "version_downloads": 0,
        "version_unique_downloads": 0,
        "version_unique_views": 1,
        "version_views": 1
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-04-30T19:12:46.758762+00:00",
      "modified": "2025-04-30T19:12:46.878974+00:00",
      "id": 15312646,
      "conceptrecid": "15312645",
      "doi": "10.5281/zenodo.15312646",
      "conceptdoi": "10.5281/zenodo.15312645",
      "doi_url": "https://doi.org/10.5281/zenodo.15312646",
      "metadata": {
        "title": "Bio-oil composition",
        "doi": "10.5281/zenodo.15312646",
        "publication_date": "2025-04-30",
        "description": "<p>Bio-oil samples are analyzed with an Agilent 7890A gas chromatography system (GC) coupled with a mass spectrometer MS 5975C-VLMSD. The GC is equipped with a 624 capillary column, which works with helium as gas carrier. The bio-oil samples are highly diluted in acetone (ca. 10 % bio-oil and 90 % acetone) before the injection in the GC-MS that occurs through an autosampler. 1 &micro;L of sample is injected for each analysis, whose run time was about 118 minutes. The column is heated according to the following temperature program: 4 minutes at 45 &deg;C, heating up to 235 &deg;C with a heating rate of 3 &deg;C/min and 50 minutes at 235 &deg;C. The sample is injected in &ldquo;split mode&rdquo; and carried by a flux of helium of 1.8 mL/min. The detector is set to scan a range of m/Z between 35 and 350; the lower limit is set to detect small species like acetic acid while avoiding causing too much baseline noise.</p>\n<p><br>Bio-oil compounds identification is carried out by matching the obtained spectra with the National Institute of Standards and Technology (NIST) library. The quantification of representative compounds is carried out with the Agilent MassHunter Quantitative Analysis (Quant My-Way) software. The calibration curve for each compound is obtained with standard solutions in acetone at weight concentrations between 1% and 0.01% (except for acetic acid, whose calibration range is between 2% and 0.4%); each calibration curve results in a R2 index &gt;0.99. Fluoranthene is added as Internal Standard (IS) at a concentration of 0.025 wt. %.</p>",
        "access_right": "embargoed",
        "embargo_date": "2026-04-30",
        "creators": [
          {
            "name": "National Research Council",
            "affiliation": null
          }
        ],
        "resource_type": {
          "title": "Dataset",
          "type": "dataset"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "grants": [
          {
            "code": "101115506",
            "internal_id": "10.13039/501100000780::101115506",
            "funder": {
              "name": "European Commission",
              "doi": "10.13039/501100000780",
              "acronym": "EC"
            },
            "title": "MILD Combustion with Nitrogen and Carbon Dioxide Reforming",
            "acronym": "MINICOR",
            "program": "HORIZON.3.1",
            "url": "https://cordis.europa.eu/projects/101115506"
          }
        ],
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "15312645"
              }
            }
          ]
        }
      },
      "title": "Bio-oil composition",
      "links": {
        "self": "https://zenodo.org/api/records/15312646",
        "self_html": "https://zenodo.org/records/15312646",
        "preview_html": "https://zenodo.org/records/15312646?preview=1",
        "doi": "https://doi.org/10.5281/zenodo.15312646",
        "self_doi": "https://doi.org/10.5281/zenodo.15312646",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15312646",
        "parent": "https://zenodo.org/api/records/15312645",
        "parent_html": "https://zenodo.org/records/15312645",
        "parent_doi": "https://doi.org/10.5281/zenodo.15312645",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15312645",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:15312646/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:15312646/sequence/default",
        "files": "https://zenodo.org/api/records/15312646/files",
        "media_files": "https://zenodo.org/api/records/15312646/media-files",
        "archive": "https://zenodo.org/api/records/15312646/files-archive",
        "archive_media": "https://zenodo.org/api/records/15312646/media-files-archive",
        "latest": "https://zenodo.org/api/records/15312646/versions/latest",
        "latest_html": "https://zenodo.org/records/15312646/latest",
        "versions": "https://zenodo.org/api/records/15312646/versions",
        "draft": "https://zenodo.org/api/records/15312646/draft",
        "reserve_doi": "https://zenodo.org/api/records/15312646/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/15312646/access/links",
        "access_grants": "https://zenodo.org/api/records/15312646/access/grants",
        "access_users": "https://zenodo.org/api/records/15312646/access/users",
        "access_request": "https://zenodo.org/api/records/15312646/access/request",
        "access": "https://zenodo.org/api/records/15312646/access",
        "communities": "https://zenodo.org/api/records/15312646/communities",
        "communities-suggestions": "https://zenodo.org/api/records/15312646/communities-suggestions",
        "requests": "https://zenodo.org/api/records/15312646/requests"
      },
      "updated": "2025-04-30T19:12:46.878974+00:00",
      "recid": "15312646",
      "revision": 4,
      "files": [],
      "swh": {},
      "owners": [
        {
          "id": "1103932"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 0,
        "unique_downloads": 0,
        "views": 1,
        "unique_views": 1,
        "version_downloads": 0,
        "version_unique_downloads": 0,
        "version_unique_views": 1,
        "version_views": 1
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-04-30T14:33:11.731019+00:00",
      "modified": "2025-04-30T14:33:11.990542+00:00",
      "id": 15310946,
      "conceptrecid": "14467875",
      "doi": "10.5281/zenodo.15310946",
      "conceptdoi": "10.5281/zenodo.14467875",
      "doi_url": "https://doi.org/10.5281/zenodo.15310946",
      "metadata": {
        "title": "Dataset of \"Enhanced Electrochemical Performance of Renewable Flexible Supercapacitors through the Synergistic Effects of Nitrogen-Doped Carbonaceous Fillers and Controlled Polypyrrole Nanostructuring on Nanocellulose Fibers\"",
        "doi": "10.5281/zenodo.15310946",
        "publication_date": "2025-04-30",
        "description": "<p>In recent years, the demand for lightweight, flexible, cost-effective and environmentally friendly energy storage devices has increased significantly. In this study, we developed polypyrrole (PPy) based flexible conductive electrodes with carbonaceous fillers derived from polypyrrole nanotubes (PPy-NT) with activated surface via KOH treatment, using a simple and environmentally friendly approach. This approach consisted of in-situ polymerization of PPy nanostructures in presence of selected carbonaceous fillers and cellulose nanofibers (CNF). CNF works as a flexible matrix for electrochemically active material. The morphology of PPy was controlled by using methyl orange azo dye (MO), popular for reliable nanostructuring of conducting polymers. The influence of morphology, textural properties and electrical conductivity of the flexible PPy-based electrodes on their electrochemical performance was investigated.&nbsp;</p>\n<p>The maximum specific capacitance was performed by electrode containing PPy-NT and CNF (172 F/g at 5 mV/s scan rate). However, significant enhancement of capacitance retention was observed in case of PPy-based electrodes enhanced by carbonaceous fillers. In order to test prepared electrodes in two electrode setup, cellulose hydrogel prepared via physical crosslinking was fabricated and successfully incorporated into supercapacitor device as a electrolyte reservoir and separator. In all electrochemical tests, 1 M sulfuric acid electrolyte was used. This study shows possible ways of using renewable materials in supercapacitors and energy storage devices.</p>",
        "access_right": "embargoed",
        "embargo_date": "2027-05-08",
        "creators": [
          {
            "name": "Lapka, Tom\u00e1\u0161",
            "affiliation": "University of Chemistry and Technology",
            "orcid": "0000-0002-1074-2337"
          },
          {
            "name": "Pau\u0161ov\u00e1, \u0160\u00e1rka",
            "affiliation": "University of Chemistry and Technology",
            "orcid": "0000-0003-2494-1510"
          },
          {
            "name": "Bouzek, Karel",
            "affiliation": "University of Chemistry and Technology",
            "orcid": "0000-0002-0394-0634"
          }
        ],
        "keywords": [
          "VZ1",
          "VSCHT",
          "214 021",
          "214 024",
          "cellulose nanofibers",
          "Polypyrrole",
          "Supercapacitor",
          "Energy storage",
          "KOH activation",
          "Flexible film",
          "Electrochemical properties"
        ],
        "dates": [
          {
            "type": "submitted",
            "description": "Sent to peer review process"
          }
        ],
        "version": "version 2",
        "language": "eng",
        "resource_type": {
          "title": "Dataset",
          "type": "dataset"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "grants": [
          {
            "code": "CZ.02.01.01/00/22_008/0004617",
            "internal_id": "037n8p820::CZ.02.01.01/00/22_008/0004617",
            "funder": {
              "name": "Ministry of Education Youth and Sports"
            },
            "title": "The Energy Conversion and Storage"
          }
        ],
        "communities": [
          {
            "id": "ecostor"
          }
        ],
        "relations": {
          "version": [
            {
              "index": 1,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "14467875"
              }
            }
          ]
        }
      },
      "title": "Dataset of \"Enhanced Electrochemical Performance of Renewable Flexible Supercapacitors through the Synergistic Effects of Nitrogen-Doped Carbonaceous Fillers and Controlled Polypyrrole Nanostructuring on Nanocellulose Fibers\"",
      "links": {
        "self": "https://zenodo.org/api/records/15310946",
        "self_html": "https://zenodo.org/records/15310946",
        "preview_html": "https://zenodo.org/records/15310946?preview=1",
        "doi": "https://doi.org/10.5281/zenodo.15310946",
        "self_doi": "https://doi.org/10.5281/zenodo.15310946",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15310946",
        "parent": "https://zenodo.org/api/records/14467875",
        "parent_html": "https://zenodo.org/records/14467875",
        "parent_doi": "https://doi.org/10.5281/zenodo.14467875",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.14467875",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:15310946/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:15310946/sequence/default",
        "files": "https://zenodo.org/api/records/15310946/files",
        "media_files": "https://zenodo.org/api/records/15310946/media-files",
        "archive": "https://zenodo.org/api/records/15310946/files-archive",
        "archive_media": "https://zenodo.org/api/records/15310946/media-files-archive",
        "latest": "https://zenodo.org/api/records/15310946/versions/latest",
        "latest_html": "https://zenodo.org/records/15310946/latest",
        "versions": "https://zenodo.org/api/records/15310946/versions",
        "draft": "https://zenodo.org/api/records/15310946/draft",
        "reserve_doi": "https://zenodo.org/api/records/15310946/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/15310946/access/links",
        "access_grants": "https://zenodo.org/api/records/15310946/access/grants",
        "access_users": "https://zenodo.org/api/records/15310946/access/users",
        "access_request": "https://zenodo.org/api/records/15310946/access/request",
        "access": "https://zenodo.org/api/records/15310946/access",
        "communities": "https://zenodo.org/api/records/15310946/communities",
        "communities-suggestions": "https://zenodo.org/api/records/15310946/communities-suggestions",
        "requests": "https://zenodo.org/api/records/15310946/requests"
      },
      "updated": "2025-04-30T14:33:11.990542+00:00",
      "recid": "15310946",
      "revision": 4,
      "files": [],
      "swh": {},
      "owners": [
        {
          "id": "1063184"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 0,
        "unique_downloads": 0,
        "views": 8,
        "unique_views": 7,
        "version_downloads": 0,
        "version_unique_downloads": 0,
        "version_unique_views": 1,
        "version_views": 1
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-04-30T12:27:39.431860+00:00",
      "modified": "2025-04-30T12:27:39.731235+00:00",
      "id": 15310117,
      "conceptrecid": "15310116",
      "doi": "10.1002/anie.202413383",
      "doi_url": "https://doi.org/10.1002/anie.202413383",
      "metadata": {
        "title": "Electrochemical C O and C N Arylation using Alternating Polarity in flow for Compound Libraries",
        "doi": "10.1002/anie.202413383",
        "publication_date": "2024-10-01",
        "description": "<p>Etherification and amination of aryl halide scaffolds are commonly used reactions in parallel medicinal&nbsp;<br>chemistry to rapidly scan structure&ndash;activity relationships with abundant building blocks. Electrochemical methods for&nbsp;<br>aryl etherification and amination demonstrate broad functional group tolerance and extended nucleophile scope&nbsp;<br>compared to traditional methods. Nevertheless, there is a need for robust and scale-transferable workflows for&nbsp;<br>electrochemical compound library synthesis. Herein we describe a platform for automated electrochemical synthesis of&nbsp;<br>C X arylation (X=NH, OH) in flow to access compound libraries. A comprehensive Design of Experiment (DoE) study&nbsp;<br>identifies an optimal protocol which generates high yields across&gt;30 aryl halide scaffolds, diverse amines (including&nbsp;<br>electron-deficient sulfonamides, sulfoximines, amides, and anilines) and alcohols (including serine residues within&nbsp;<br>peptides). Reaction sequences are automated on commercially available equipment to generate libraries of anilines and&nbsp;<br>aryl ethers. The unprecedented application of potentiostatic alternating polarity in flow is essential to avoid accumulating&nbsp;<br>electrode passivation. Moreover, it enables reactions to be performed in air, without supporting electrolyte and with high&nbsp;<br>reproducibility over consecutive runs. Our method represents a powerful means to rapidly generate nucleophile&nbsp;<br>independent C X arylation compound libraries using flow electrochemistry.</p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Morgan, Jennifer",
            "affiliation": null
          },
          {
            "name": "Kuijpers, Koen P. L.",
            "affiliation": null
          },
          {
            "name": "Fanfair, Dayne",
            "affiliation": null
          },
          {
            "name": "Tang, Bingqing",
            "affiliation": null
          },
          {
            "name": "Bartkowiak, Karolina",
            "affiliation": null
          },
          {
            "name": "van Eynde, Lars",
            "affiliation": null
          },
          {
            "name": "Renders, Evelien",
            "affiliation": null
          },
          {
            "name": "Alcazar, Jesus",
            "affiliation": null
          },
          {
            "name": "Buijnsters, Peter J. J. A.",
            "affiliation": null
          },
          {
            "name": "Carvalho, Marie-Ambre",
            "affiliation": null
          },
          {
            "name": "Jones, Alexander X.",
            "affiliation": null
          }
        ],
        "language": "eng",
        "resource_type": {
          "title": "Publication",
          "type": "publication"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "15310116"
              }
            }
          ]
        }
      },
      "title": "Electrochemical C O and C N Arylation using Alternating Polarity in flow for Compound Libraries",
      "links": {
        "self": "https://zenodo.org/api/records/15310117",
        "self_html": "https://zenodo.org/records/15310117",
        "preview_html": "https://zenodo.org/records/15310117?preview=1",
        "doi": "https://doi.org/10.1002/anie.202413383",
        "self_doi": "https://doi.org/10.1002/anie.202413383",
        "self_doi_html": "https://zenodo.org/doi/10.1002/anie.202413383",
        "parent": "https://zenodo.org/api/records/15310116",
        "parent_html": "https://zenodo.org/records/15310116",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:15310117/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:15310117/sequence/default",
        "files": "https://zenodo.org/api/records/15310117/files",
        "media_files": "https://zenodo.org/api/records/15310117/media-files",
        "thumbnails": {
          "10": "https://zenodo.org/api/iiif/record:15310117:Angew-Chem-Int-Ed-2024-Morvan-Electrochemical-C-O-and-C-N-Arylation-using-Alternating-Polarity-in-flow-for-Compound.pdf/full/^10,/0/default.jpg",
          "50": "https://zenodo.org/api/iiif/record:15310117:Angew-Chem-Int-Ed-2024-Morvan-Electrochemical-C-O-and-C-N-Arylation-using-Alternating-Polarity-in-flow-for-Compound.pdf/full/^50,/0/default.jpg",
          "100": "https://zenodo.org/api/iiif/record:15310117:Angew-Chem-Int-Ed-2024-Morvan-Electrochemical-C-O-and-C-N-Arylation-using-Alternating-Polarity-in-flow-for-Compound.pdf/full/^100,/0/default.jpg",
          "250": "https://zenodo.org/api/iiif/record:15310117:Angew-Chem-Int-Ed-2024-Morvan-Electrochemical-C-O-and-C-N-Arylation-using-Alternating-Polarity-in-flow-for-Compound.pdf/full/^250,/0/default.jpg",
          "750": "https://zenodo.org/api/iiif/record:15310117:Angew-Chem-Int-Ed-2024-Morvan-Electrochemical-C-O-and-C-N-Arylation-using-Alternating-Polarity-in-flow-for-Compound.pdf/full/^750,/0/default.jpg",
          "1200": "https://zenodo.org/api/iiif/record:15310117:Angew-Chem-Int-Ed-2024-Morvan-Electrochemical-C-O-and-C-N-Arylation-using-Alternating-Polarity-in-flow-for-Compound.pdf/full/^1200,/0/default.jpg"
        },
        "archive": "https://zenodo.org/api/records/15310117/files-archive",
        "archive_media": "https://zenodo.org/api/records/15310117/media-files-archive",
        "latest": "https://zenodo.org/api/records/15310117/versions/latest",
        "latest_html": "https://zenodo.org/records/15310117/latest",
        "versions": "https://zenodo.org/api/records/15310117/versions",
        "draft": "https://zenodo.org/api/records/15310117/draft",
        "reserve_doi": "https://zenodo.org/api/records/15310117/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/15310117/access/links",
        "access_grants": "https://zenodo.org/api/records/15310117/access/grants",
        "access_users": "https://zenodo.org/api/records/15310117/access/users",
        "access_request": "https://zenodo.org/api/records/15310117/access/request",
        "access": "https://zenodo.org/api/records/15310117/access",
        "communities": "https://zenodo.org/api/records/15310117/communities",
        "communities-suggestions": "https://zenodo.org/api/records/15310117/communities-suggestions",
        "requests": "https://zenodo.org/api/records/15310117/requests"
      },
      "updated": "2025-04-30T12:27:39.731235+00:00",
      "recid": "15310117",
      "revision": 4,
      "files": [
        {
          "id": "08d3eab7-9b9a-427a-80cc-0032cab03395",
          "key": "Angew-Chem-Int-Ed-2024-Morvan-Electrochemical-C-O-and-C-N-Arylation-using-Alternating-Polarity-in-flow-for-Compound.pdf",
          "size": 12897389,
          "checksum": "md5:e85054c8233c652d356320ca0c4d5463",
          "links": {
            "self": "https://zenodo.org/api/records/15310117/files/Angew-Chem-Int-Ed-2024-Morvan-Electrochemical-C-O-and-C-N-Arylation-using-Alternating-Polarity-in-flow-for-Compound.pdf/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "1281074"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 1,
        "unique_downloads": 1,
        "views": 1,
        "unique_views": 1,
        "version_downloads": 1,
        "version_unique_downloads": 1,
        "version_unique_views": 1,
        "version_views": 1
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-04-29T08:15:39.394549+00:00",
      "modified": "2025-04-29T08:20:35.226361+00:00",
      "id": 15301607,
      "conceptrecid": "14957320",
      "doi": "10.5281/zenodo.15301607",
      "conceptdoi": "10.5281/zenodo.14957320",
      "doi_url": "https://doi.org/10.5281/zenodo.15301607",
      "metadata": {
        "title": "TRISTAN gadoxetate kinetics",
        "doi": "10.5281/zenodo.15301607",
        "publication_date": "2025-04-29",
        "description": "<h1>Database</h1>\n<p><strong>Summary</strong></p>\n<p>Signal versus time curves measured with gadoxetate-enhanced MRI in the liver, with and without drugs.</p>\n<p><strong>Subjects</strong></p>\n<p>Human healthy volunteers, patients and rats.</p>\n<p><strong>Background</strong></p>\n<p>The data are taken from a series of preclinical and clinical studies performed by the&nbsp;<a href=\"https://www.imi-tristan.eu\">TRISTAN project</a>, in the period 2018-2024. The aim of these studies was to test if the effect of drugs on uptake and excretory function of the liver can be measured reliably with dynamic gadoxetate-enhanced MRI. Combined these studies provide proof of concept for a new MRI-based biomarker to predict the risk of liver-mediated drug-drug interactions, and of drug-induced liver injury.&nbsp;</p>\n<p>The data have been used to support a submission to the FDA's biomarker qualification program (<a href=\"https://www.fda.gov/media/149415/download\">details</a>).</p>\n<p><strong>Format</strong></p>\n<p>All data are in dmr format - a folder with three csv files:</p>\n<ul>\n<li><strong>data.csv</strong>: Data dictionary</li>\n<li><strong>rois.csv</strong>: ROI curves</li>\n<li><strong>pars.csv</strong>: Subject parameters</li>\n</ul>\n<p>The data can be read and manipulated interactively with common applications such as excel, or programmatically with the python package <a href=\"https://openmiblab.github.io/pydmr/\">pydmr</a>.&nbsp;</p>\n<p><strong>Example usage</strong></p>\n<ul>\n<li>Rats multiple dosing: <a href=\"https://dcmri.org/generated/examples/liver/plot_tristan_mdosing.html\">https://dcmri.org/examples/liver/plot_tristan_mdosing.html</a></li>\n<li>Rat six test drugs: <a href=\"https://dcmri.org/generated/examples/liver/plot_tristan6drugs.html\">https://dcmri.org/examples/liver/plot_tristan6drugs.html</a></li>\n<li>Rat reproducibility: <a href=\"https://dcmri.org/generated/examples/liver/plot_tristan_repro.html\">https://dcmri.org/examples/liver/plot_tristan_repro.html</a></li>\n<li>Healthy volunteers: <a href=\"https://dcmri.org/generated/examples/liver/plot_tristan_volunteers_2scan.html\">https://dcmri.org/examples/liver/plot_tristan_volunteers_2scan.html</a></li>\n<li>Patients: <a href=\"https://dcmri.org/generated/examples/liver/plot_tristan_patients.html\">https://dcmri.org/examples/liver/plot_tristan_patients.html</a><strong> </strong></li>\n</ul>\n<p><strong>Version history</strong></p>\n<ul>\n<li>v0.0.1\n<ul>\n<li>Removed duplicate human results and combined all controls without treatment in a single file</li>\n<li>Unique naming of subject ID's by adding a study acronym to the subject number: LDS for Leeds subjects, SHF for Sheffield subjects and GOT for Gothenburg subjects</li>\n</ul>\n</li>\n<li>v0.0.0\n<ul>\n<li>Combined various formats of previous studies in a coherent dmr format</li>\n</ul>\n</li>\n</ul>\n<h1>Datasets</h1>\n<p><strong><em>tristan_humans_healthy_rifampicin</em></strong></p>\n<div>The data were acquired in the aorta and liver of 8 healthy volunteers with dynamic gadoxetate-enhanced MRI, before and after administration of a drug (rifampicin) which is known to inhibit liver function. The assessments were done on two separate visits at least 2 weeks apart. On each visit, the volunteer had two scans each with a separate contrast agent injection of a quarter dose each. the scans were separated by a gap of about 1 hour to enable gadoxetate to clear from the liver. This design was deemed necessary for reliable measurement of excretion rate when liver function was inhibited.</div>\n<div><br>The research question was to what extent rifampicin inhibits&nbsp;gadoxetate uptake rate from the extracellular space into the&nbsp;liver hepatocytes (khe, mL/min/100mL) and excretion rate from&nbsp;hepatocytes to bile (kbh, mL/100mL/min). 2 of the volunteers only&nbsp;had the baseline assessment, the other 8 volunteers completed the&nbsp;full study. The results showed consistent and strong inhibition of&nbsp;khe (95%) and kbh (40%) by rifampicin. This implies that&nbsp;rifampicin poses a risk of drug-drug interactions (DDI), meaning&nbsp;it can cause another drug to circulate in the body for far longer&nbsp;than expected, potentially causing harm or raising a need for dose&nbsp;adjustment.</div>\n<div>\n<div>&nbsp;</div>\n<div>The following data are available for each subject (see data.csv for more detail):</div>\n<div>\n<ul>\n<li><strong>time_1</strong>: acquisition times of the first scan</li>\n<li><strong>time_2</strong>: acquisition times of the second scan</li>\n<li><strong>aorta_1</strong>: aorta signals in the first scan</li>\n<li><strong>aorta_2</strong>: aorta signals in the second scan</li>\n<li><strong>liver_1</strong>: liver signals in the first scan</li>\n<li><strong>liver_2</strong>: liver signals in the second scan</li>\n<li><strong>aorta_1_accept</strong>: valid aorta signals in the first scan</li>\n<li><strong>aorta_2_accept</strong>: valid aorta signals in the second scan</li>\n<li><strong>liver_1_accept</strong>: valid liver signals in the first scan</li>\n<li><strong>liver_2_accept</strong>: valid liver signals in the second scan</li>\n<li><strong>weight</strong>: subject weight in kg.</li>\n<li><strong>dose_1</strong>: contrast agent doses of first scan in mL/kg.</li>\n<li><strong>dose_2</strong>: contrast agent doses of second scan in mL/kg.</li>\n<li><strong>rate</strong>: contrast agent injection rate in mL/sec.</li>\n<li><strong>FA_1</strong>: Flip angle in degrees of the first scan</li>\n<li><strong>FA_2</strong>: Flip angle in degrees of the second scan</li>\n<li><strong>TR</strong>: repetition time in sec</li>\n<li><strong>t0</strong>: baseline length</li>\n<li><strong>T1_aorta_1</strong>: precontrast T1 of blood</li>\n<li><strong>T1_aorta_2</strong>: T1 of blood after 1st dynamic</li>\n<li><strong>T1_aorta_3</strong>: T1 of blood at the start of the 2nd scan</li>\n<li><strong>T1_liver_1</strong>: precontrast T1 of the liver</li>\n<li><strong>T1_liver_2</strong>: T1 of the liver after 1st dynamic</li>\n<li><strong>T1_liver_3</strong>: T1 of the liver at the start of the 2nd scan</li>\n<li><strong>liver_volume</strong>: liver volume in mL.</li>\n</ul>\n</div>\n<div>\n<div>Please reference the following abstract when using these data (manuscript in preparation):</div>\n</div>\n<div>Thazin Min, Marta Tibiletti, Paul Hockings, Aleksandra Galetin, Ebony Gunwhy, Gerry Kenna, Nicola Melillo, Geoff JM Parker, Gunnar Schuetz, Daniel Scotcher, John Waterton, Ian Rowe, and Steven Sourbron. Measurement of liver function with dynamic gadoxetate-enhanced MRI: a validation study in healthy volunteers. <a href=\"https://archive.ismrm.org/2024/4015.html\">Proc Intl Soc Mag Reson Med, Singapore 2024.</a></div>\n<br>\n<div><strong><em>tristan_humans_healthy_metformin</em></strong></div>\n<div>&nbsp;</div>\n<div>Data from a similar experiment as the rifampicin study in healthy volunteers, but with the drug metformin and performed in another center with a different scanner vendor. The study includes 6 volunteers.</div>\n<div>&nbsp;</div>\n<div>The variables are the same as in the rifampicin study.</div>\n<div>&nbsp;</div>\n<div>\n<div>Manuscript in preparation.</div>\n</div>\n<div>&nbsp;</div>\n<div>\n<div><strong><em>tristan_humans_healthy_ciclosporin</em></strong></div>\n<div>&nbsp;</div>\n<div>Data from a similar experiment as the metformin study in healthy volunteers, but with the drug ciclosporin.&nbsp;</div>\n<div>&nbsp;</div>\n<div>The variables are the same as in the rifampicin study.</div>\n<div>&nbsp;</div>\n<div>\n<div>Manuscript in preparation.</div>\n</div>\n<div>&nbsp;</div>\n<div>\n<div><strong><em>tristan_humans_healthy_controls</em></strong></div>\n<div>&nbsp;</div>\n<div>Five subjects enrolled in the rifampicin, metformin and ciclosporin studies had their baseline assessment but did not go on to have the the treatment visit, for various reasons. These data are combined together in this file. They can be added to the baseline data of the other studies to form a control cohort.</div>\n</div>\n</div>\n<br>\n<div><strong><em>tristan_humans_patients_rifampicin</em></strong></div>\n<div>&nbsp;</div>\nThe study aimed to demonstrates the effect of rifampicin on liver function of patients with impaired function.</div>\n<div>&nbsp;</div>\n<div>The data were acquired in the aorta and liver in 3 patients with dynamic gadoxetate-enhanced MRI. The study participants take rifampicin as part of their routine clinical workup, with an aim to promote their liver function. For this study, they were taken off rifampicin 3 days before the first scan, and placed back on rifampicin 3 days before the second scan. The aim was to determine the effect if rifampicin in uptake and excretion function of the liver.</div>\n<div><br>The data confirmed that patients had significantly reduced uptake&nbsp;and excretion function in the absence of rifampicin. Rifampicin&nbsp;administration improved their excretory function but had no effect&nbsp;on their uptake function.</div>\n<div>&nbsp;</div>\n<div>The variables are the same as in the rifampicin study in healthy volunteers, but the patient study was performed in a different center.</div>\n<div>&nbsp;</div>\n<div>Manuscript in preparation.</div>\n<div>&nbsp;</div>\n<div>\n<div><strong><em>tristan_rats_healthy_six_drugs</em></strong></div>\n<div>&nbsp;</div>\nThe study presented here measured gadoxetate uptake and excretion&nbsp;in healthy rats before and after injection of 6 test drugs (up to&nbsp;6 rats per drug). Studies were performed in preclinical MRI&nbsp;scanners at 3 different centers and 2 different field strengths.</div>\n<div>\n<div>&nbsp;</div>\n<div>Results demonstrated that two of the tested drugs (rifampicin and cyclosporine) showed strong inhibition of both uptake and excretion. One drug (ketoconazole) inhibited uptake but not excretion. Three drugs (pioglitazone, bosentan and asunaprevir) inhibited excretion but not uptake.</div>\n<br>\n<div>The following data are available for each subject (see data.csv for more detail):</div>\n<ul>\n<li><strong>time</strong>: array of time points in sec</li>\n<li><strong>spleen</strong>: array of spleen signals in arbitrary units</li>\n<li><strong>liver</strong>: array of liver signals in arbitrary units.</li>\n<li><strong>FA</strong>: Flip angle in degrees</li>\n<li><strong>TR</strong>: repetition time in sec</li>\n<li><strong>n0</strong>: number of precontrast acquisitions</li>\n<li><strong>study</strong>: an integer identifying the substudy the scan was taken in</li>\n<li><strong>subject</strong>: a study-specific identifier of the subject in the range 1-6.</li>\n<li><strong>visit</strong>: either 1 (baseline) or 2 (drug or vehicle/saline).</li>\n<li><strong>center</strong>: center wehere the study was performed, either E, G or D.</li>\n<li><strong>field_strength</strong>: B0-field of scanner on whuch the study was performed</li>\n<li><strong>substance</strong>: what was injected, eg. saline, vehicle or drug name.</li>\n<li><strong>BAT</strong>: Bolus arrival time</li>\n<li><strong>duration</strong>: duration on the injection in sec.</li>\n</ul>\nPlease reference the following paper when using these data:</div>\n<div><br>\n<div>Melillo N, Scotcher D, Kenna JG, Green C, Hines CDG, Laitinen I,&nbsp;Hockings PD, Ogungbenro K, Gunwhy ER, Sourbron S, et al. Use of&nbsp;In Vivo Imaging and Physiologically-Based Kinetic Modelling to&nbsp;Predict Hepatic Transporter Mediated Drug&ndash;Drug Interactions in&nbsp;Rats. <a href=\"https://doi.org/10.3390/pharmaceutics15030896\">Pharmaceutics. 2023; 15(3):896</a>.</div>\n<br><strong><em>tristan_rats_healthy_reproducibility</em></strong></div>\n<div><br>Data from a study that aimed to determine the repreducibility&nbsp;and repeatability of gadoxetate uptake and excretion measurements&nbsp;in healthy rats. Data were acquired in different centers and field&nbsp;strengths to identify contributing factors. Some of the studies&nbsp;involved repeat scans in the same subject. In some studies data&nbsp;on the second day were taken after adminstration of a drug&nbsp;(rifampicin) to test if effect sizes were reproducible.<br>\n<div>&nbsp;</div>\nAvailable data for each subject are the same as in the six drugs study (see data.csv for more detail)</div>\n<div><br>Please reference the following paper when using these data:</div>\n<div>\n<div>&nbsp;</div>\n<div>Ebony R. Gunwhy, Catherine D. G. Hines, Claudia Green, Iina Laitinen, Sirisha Tadimalla, Paul D. Hockings, Gunnar Sch&uuml;tz, J. Gerry Kenna, Steven Sourbron, and John C. Waterton. Assessment of hepatic transporter function in rats using dynamic gadoxetate-enhanced MRI: A reproducibility study. MAGMA<br>. 2024 Aug;37(4):697-708. <a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11417070/\">doi: 10.1007/s10334-024-01192-5</a>.&nbsp;</div>\n<br><strong><em>tristan_rats_healthy_multiple_dosing</em></strong><br>\n<div>&nbsp;</div>\n<div>These data are taken from a preclinical study&nbsp;which aimed to investigate the potential of gadoxetate-enhanced&nbsp;DCE-MRI to study acute inhibition of hepatocyte transporters of&nbsp;drug-induced liver injury (DILI) causing drugs, and to study&nbsp;potential changes in transporter function after chronic dosing.</div>\n<br>\n<div>\n<div>Available data for each subject are the same as in the six drugs study (see data.csv for more detail)</div>\n<div><br>Please reference the following abstract when using these data (manuscript in preparation):</div>\n</div>\n<br>\n<div>Mikael Montelius, Steven Sourbron, Nicola Melillo, Daniel Scotcher,&nbsp;Aleksandra Galetin, Gunnar Schuetz, Claudia Green, Edvin Johansson,&nbsp;John C. Waterton, and Paul Hockings. Acute and chronic rifampicin&nbsp;effect on gadoxetate uptake in rats using gadoxetate DCE-MRI. <a href=\"https://archive.ismrm.org/2021/2764.html\">Int&nbsp;Soc Mag Reson Med 2021; 2674.</a></div>\n</div>",
        "access_right": "open",
        "creators": [
          {
            "name": "TRISTAN consortium",
            "affiliation": null
          }
        ],
        "version": "0.0.2",
        "custom": {
          "code:developmentStatus": {
            "id": "active",
            "title": {
              "en": "Active"
            }
          }
        },
        "resource_type": {
          "title": "Dataset",
          "type": "dataset"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "grants": [
          {
            "code": "116106",
            "internal_id": "10.13039/501100000780::116106",
            "funder": {
              "name": "European Commission",
              "doi": "10.13039/501100000780",
              "acronym": "EC"
            },
            "title": "Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106",
            "acronym": "IB4SD-TRISTAN",
            "program": "H2020-EU.3.1.",
            "url": "https://cordis.europa.eu/projects/116106"
          }
        ],
        "communities": [
          {
            "id": "miblab"
          }
        ],
        "relations": {
          "version": [
            {
              "index": 2,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "14957320"
              }
            }
          ]
        }
      },
      "title": "TRISTAN gadoxetate kinetics",
      "links": {
        "self": "https://zenodo.org/api/records/15301607",
        "self_html": "https://zenodo.org/records/15301607",
        "preview_html": "https://zenodo.org/records/15301607?preview=1",
        "doi": "https://doi.org/10.5281/zenodo.15301607",
        "self_doi": "https://doi.org/10.5281/zenodo.15301607",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15301607",
        "parent": "https://zenodo.org/api/records/14957320",
        "parent_html": "https://zenodo.org/records/14957320",
        "parent_doi": "https://doi.org/10.5281/zenodo.14957320",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.14957320",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:15301607/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:15301607/sequence/default",
        "files": "https://zenodo.org/api/records/15301607/files",
        "media_files": "https://zenodo.org/api/records/15301607/media-files",
        "archive": "https://zenodo.org/api/records/15301607/files-archive",
        "archive_media": "https://zenodo.org/api/records/15301607/media-files-archive",
        "latest": "https://zenodo.org/api/records/15301607/versions/latest",
        "latest_html": "https://zenodo.org/records/15301607/latest",
        "versions": "https://zenodo.org/api/records/15301607/versions",
        "draft": "https://zenodo.org/api/records/15301607/draft",
        "reserve_doi": "https://zenodo.org/api/records/15301607/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/15301607/access/links",
        "access_grants": "https://zenodo.org/api/records/15301607/access/grants",
        "access_users": "https://zenodo.org/api/records/15301607/access/users",
        "access_request": "https://zenodo.org/api/records/15301607/access/request",
        "access": "https://zenodo.org/api/records/15301607/access",
        "communities": "https://zenodo.org/api/records/15301607/communities",
        "communities-suggestions": "https://zenodo.org/api/records/15301607/communities-suggestions",
        "requests": "https://zenodo.org/api/records/15301607/requests"
      },
      "updated": "2025-04-29T08:20:35.226361+00:00",
      "recid": "15301607",
      "revision": 6,
      "files": [
        {
          "id": "c94e4d03-c090-4f5b-b2e1-5db60d4be27b",
          "key": "tristan_humans_healthy_ciclosporin.dmr.zip",
          "size": 528709,
          "checksum": "md5:91e5ef15f2f44c26b8af16baf5ef3bf6",
          "links": {
            "self": "https://zenodo.org/api/records/15301607/files/tristan_humans_healthy_ciclosporin.dmr.zip/content"
          }
        },
        {
          "id": "7f0b97c8-f919-4e63-ad4a-aa1da411bbf3",
          "key": "tristan_humans_healthy_controls.dmr.zip",
          "size": 244190,
          "checksum": "md5:ec64cbdf86261e9210555582e4d849c3",
          "links": {
            "self": "https://zenodo.org/api/records/15301607/files/tristan_humans_healthy_controls.dmr.zip/content"
          }
        },
        {
          "id": "546c5355-013a-4327-97f6-3b77100948c8",
          "key": "tristan_humans_patients_rifampicin.dmr.zip",
          "size": 186476,
          "checksum": "md5:c17b17f60350c7032e89809d956c135c",
          "links": {
            "self": "https://zenodo.org/api/records/15301607/files/tristan_humans_patients_rifampicin.dmr.zip/content"
          }
        },
        {
          "id": "378374db-8bb2-4d23-8b1c-20127fa04bbc",
          "key": "tristan_rats_healthy_six_drugs.dmr.zip",
          "size": 15556,
          "checksum": "md5:f3412bce8b6cabdfb3c97a26d915413d",
          "links": {
            "self": "https://zenodo.org/api/records/15301607/files/tristan_rats_healthy_six_drugs.dmr.zip/content"
          }
        },
        {
          "id": "74dd2bc4-b9f1-4279-8313-be0b7b29ef13",
          "key": "tristan_humans_healthy_metformin.dmr.zip",
          "size": 481508,
          "checksum": "md5:a3446a00533d6198ea580b7dbfcde5dc",
          "links": {
            "self": "https://zenodo.org/api/records/15301607/files/tristan_humans_healthy_metformin.dmr.zip/content"
          }
        },
        {
          "id": "4f9c47e0-c6af-473a-9411-e68bbc066023",
          "key": "tristan_rats_healthy_multiple_dosing.dmr.zip",
          "size": 27210,
          "checksum": "md5:0d3ce85913056f4df8b0c526959c3998",
          "links": {
            "self": "https://zenodo.org/api/records/15301607/files/tristan_rats_healthy_multiple_dosing.dmr.zip/content"
          }
        },
        {
          "id": "bbc3e20d-dcb2-4bb8-be5d-146a9b93b4a6",
          "key": "tristan_humans_healthy_rifampicin.dmr.zip",
          "size": 1558482,
          "checksum": "md5:4c349447fc3a00654b35922325b3d5f1",
          "links": {
            "self": "https://zenodo.org/api/records/15301607/files/tristan_humans_healthy_rifampicin.dmr.zip/content"
          }
        },
        {
          "id": "963f1825-e071-4af4-9ebc-8736f0d52297",
          "key": "tristan_rats_healthy_reproducibility.dmr.zip",
          "size": 26358,
          "checksum": "md5:e9ebda6086dcda144a7cb8f4c5a672f6",
          "links": {
            "self": "https://zenodo.org/api/records/15301607/files/tristan_rats_healthy_reproducibility.dmr.zip/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "109478"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 387,
        "unique_downloads": 385,
        "views": 146,
        "unique_views": 133,
        "version_downloads": 40,
        "version_unique_downloads": 40,
        "version_unique_views": 14,
        "version_views": 15
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-04-29T06:32:43.315849+00:00",
      "modified": "2025-04-29T06:32:43.578137+00:00",
      "id": 15301112,
      "conceptrecid": "15301111",
      "doi": "10.5281/zenodo.15301112",
      "conceptdoi": "10.5281/zenodo.15301111",
      "doi_url": "https://doi.org/10.5281/zenodo.15301112",
      "metadata": {
        "title": "Integrating Aesthetic and Reconstructive Surgery: A Case Report on Abdominoplasty with Polypropylene Mesh for Rectus Diastasis and Ventral Hernia Repair",
        "doi": "10.5281/zenodo.15301112",
        "publication_date": "2025-04-29",
        "description": "<p>Background: Rectus abdominis diastasis (RAD) is the excessive widening of the midline separation between rectus abdominis muscles, commonly seen in postpartum women and middle-aged men with central obesity. Severe cases can cause abdominal wall dysfunction and ventral hernias, necessitating surgical intervention. This report highlights a collaborative approach integrating aesthetic and functional reconstruction.<br>Case Report: A 41-year-old woman presented with persistent abdominal bulging after her third vaginal delivery. A CT scan confirmed a 7 cm RAD with a ventral hernia. Given the need for both functional repair and cosmetic enhancement, a multidisciplinary team performed the surgery. The plastic surgery team began with an abdominoplasty incision, followed by the digestive surgeon&rsquo;s laparotomy for abdominal wall reconstruction with polypropylene mesh. The procedure concluded with aesthetic refinement by the plastic surgeon. The patient recovered well, with significant symptomatic improvement and no complications.&nbsp;<br>Discussion: This case emphasizes the value of an interdisciplinary approach in managing RAD with ventral hernias. Combining abdominoplasty with mesh-reinforced repair offers both functional and aesthetic benefits. Mesh reinforcement ensures durability and prevents recurrence, making it superior to suture plication alone. Collaboration between plastic and digestive surgeons enables comprehensive restoration of abdominal wall integrity while achieving optimal cosmetic outcomes.<br>Conclusion: A combined surgical approach using abdominoplasty and polypropylene mesh reinforcement effectively addresses both functional and aesthetic concerns in RAD with ventral hernia, ensuring long-term structural integrity and enhanced patient satisfaction.</p>\n<p>&nbsp;</p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Febe Alodia Widjaja",
            "affiliation": "Intern of Division of Plastic Reconstructive and Aesthetic Surgery, Department of Surgery, RSPAL Dr. Ramelan Hospital, Surabaya, Indonesia"
          },
          {
            "name": "Bambang Wicaksono",
            "affiliation": "Division of Plastic Reconstructive and Aesthetic Surgery Division, Department of Surgery, RSPAL Dr. Ramelan Hospital, Surabaya, Indonesia"
          },
          {
            "name": "Timotius Hansen Arista",
            "affiliation": "Division of Plastic Reconstructive and Aesthetic Surgery Division, Department of Surgery, RSPAL Dr. Ramelan Hospital, Surabaya, Indonesia"
          }
        ],
        "keywords": [
          "Diastasis recti, Ventral Hernia, Abdominoplasty, Polypropylene Mesh."
        ],
        "language": "ang",
        "resource_type": {
          "title": "Journal article",
          "type": "publication",
          "subtype": "article"
        },
        "journal": {
          "issue": "04",
          "pages": "234-239",
          "title": "INTERNATIONAL JOURNAL OF HEALTH & MEDICAL RESEARCH",
          "volume": "04"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "15301111"
              }
            }
          ]
        }
      },
      "title": "Integrating Aesthetic and Reconstructive Surgery: A Case Report on Abdominoplasty with Polypropylene Mesh for Rectus Diastasis and Ventral Hernia Repair",
      "links": {
        "self": "https://zenodo.org/api/records/15301112",
        "self_html": "https://zenodo.org/records/15301112",
        "preview_html": "https://zenodo.org/records/15301112?preview=1",
        "doi": "https://doi.org/10.5281/zenodo.15301112",
        "self_doi": "https://doi.org/10.5281/zenodo.15301112",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15301112",
        "parent": "https://zenodo.org/api/records/15301111",
        "parent_html": "https://zenodo.org/records/15301111",
        "parent_doi": "https://doi.org/10.5281/zenodo.15301111",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15301111",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:15301112/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:15301112/sequence/default",
        "files": "https://zenodo.org/api/records/15301112/files",
        "media_files": "https://zenodo.org/api/records/15301112/media-files",
        "thumbnails": {
          "10": "https://zenodo.org/api/iiif/record:15301112:5.pdf/full/^10,/0/default.jpg",
          "50": "https://zenodo.org/api/iiif/record:15301112:5.pdf/full/^50,/0/default.jpg",
          "100": "https://zenodo.org/api/iiif/record:15301112:5.pdf/full/^100,/0/default.jpg",
          "250": "https://zenodo.org/api/iiif/record:15301112:5.pdf/full/^250,/0/default.jpg",
          "750": "https://zenodo.org/api/iiif/record:15301112:5.pdf/full/^750,/0/default.jpg",
          "1200": "https://zenodo.org/api/iiif/record:15301112:5.pdf/full/^1200,/0/default.jpg"
        },
        "archive": "https://zenodo.org/api/records/15301112/files-archive",
        "archive_media": "https://zenodo.org/api/records/15301112/media-files-archive",
        "latest": "https://zenodo.org/api/records/15301112/versions/latest",
        "latest_html": "https://zenodo.org/records/15301112/latest",
        "versions": "https://zenodo.org/api/records/15301112/versions",
        "draft": "https://zenodo.org/api/records/15301112/draft",
        "reserve_doi": "https://zenodo.org/api/records/15301112/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/15301112/access/links",
        "access_grants": "https://zenodo.org/api/records/15301112/access/grants",
        "access_users": "https://zenodo.org/api/records/15301112/access/users",
        "access_request": "https://zenodo.org/api/records/15301112/access/request",
        "access": "https://zenodo.org/api/records/15301112/access",
        "communities": "https://zenodo.org/api/records/15301112/communities",
        "communities-suggestions": "https://zenodo.org/api/records/15301112/communities-suggestions",
        "requests": "https://zenodo.org/api/records/15301112/requests"
      },
      "updated": "2025-04-29T06:32:43.578137+00:00",
      "recid": "15301112",
      "revision": 4,
      "files": [
        {
          "id": "f15732c8-f567-4d8f-ae42-ca041e8be510",
          "key": "5.pdf",
          "size": 193673,
          "checksum": "md5:4e7973f0b13259f0d21c7d9b1e69d992",
          "links": {
            "self": "https://zenodo.org/api/records/15301112/files/5.pdf/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "409570"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 4,
        "unique_downloads": 3,
        "views": 3,
        "unique_views": 3,
        "version_downloads": 4,
        "version_unique_downloads": 3,
        "version_unique_views": 3,
        "version_views": 3
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-04-29T05:58:30.461940+00:00",
      "modified": "2025-04-29T05:58:30.606760+00:00",
      "id": 15300759,
      "conceptrecid": "15300758",
      "doi": "10.5281/zenodo.15300759",
      "conceptdoi": "10.5281/zenodo.15300758",
      "doi_url": "https://doi.org/10.5281/zenodo.15300759",
      "metadata": {
        "title": "Global Non-Small-Cell Lung Cancer Drug Market 2024 To 2033",
        "doi": "10.5281/zenodo.15300759",
        "publication_date": "2024-04-15",
        "description": "<p>Non-Small-Cell Lung Cancer Drug Market Size, Trends and Insights By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung Cancer, Pulmonary Neuroendocrine Tumours, Mediastina Tumours, Mesothelioma, Chest Wall Tumours), By Application (Adenocarcinomas, Squamous Cell Carcinoma, Large Cell Carcinomas, Others), By Molecule Type (Small Molecules, Biologics), By Drug Class (Alkylating Agents, Antimetabolites, EGFR Inhibitors, Mitotic Inhibitors, Multi-kinase Inhibitors, Others), By Treatment Type (Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy, Others), By Diagnosis (CT scan, X-Rays, Sputum Cytology, Bronchoscopy, Laboratory Tests, Thoracoscopy, Others), By End User (Hospitals, Homecare, Specialty Clinics, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024&ndash;2033.</p>\n<p><strong>Reports Description</strong></p>\n<p>As per the current market research conducted by the CMI Team, the global <a href=\"https://www.custommarketinsights.com/report/non-small-cell-lung-cancer-drug-market/\" target=\"_blank\" rel=\"noopener\"><strong>Non-Small-Cell Lung Cancer Drug Market</strong></a> is expected to record a CAGR of <strong>8.1%</strong> from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD <strong>34,175.6 Million</strong>. By 2033, the valuation is anticipated to reach USD <strong>68,888.6 Million</strong><strong>.</strong></p>\n<p>The Non-Small-Cell Lung Cancer (NSCLC) drug market encompasses the development, manufacturing, and commercialization of pharmaceutical products aimed at treating NSCLC, the most common type of lung cancer. These drugs include targeted therapies, immunotherapies, chemotherapy agents, and supportive care medications.</p>\n<p>With advancements in precision medicine and biomarker-driven approaches, the NSCLC drug market is witnessing a shift towards personalized treatment regimens tailored to individual patient profiles. The market is characterized by robust clinical research, regulatory approvals for novel therapeutics, and a focus on improving patient outcomes through innovative treatment modalities and multidisciplinary care approaches.</p>\n<p>For more information, <strong>DOWNLOAD FREE SAMPLE </strong>Now at <a href=\"https://www.custommarketinsights.com/request-for-free-sample/?reportid=45705\" target=\"_blank\" rel=\"noopener\">https://www.custommarketinsights.com/request-for-free-sample/?reportid=45705</a></p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Sirsat, Nitin",
            "affiliation": null
          }
        ],
        "keywords": [
          "Non-Small-Cell Lung Cancer Drug Market",
          "Non-Small-Cell Lung Cancer Drug Market Size",
          "Non-Small-Cell Lung Cancer Drug Market Share",
          "Non-Small-Cell Lung Cancer Drug Market Trends",
          "Non-Small-Cell Lung Cancer Drug Market Report",
          "Non-Small-Cell Lung Cancer Drug Market Research"
        ],
        "language": "eng",
        "resource_type": {
          "title": "Dataset",
          "type": "dataset"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "15300758"
              }
            }
          ]
        }
      },
      "title": "Global Non-Small-Cell Lung Cancer Drug Market 2024 To 2033",
      "links": {
        "self": "https://zenodo.org/api/records/15300759",
        "self_html": "https://zenodo.org/records/15300759",
        "preview_html": "https://zenodo.org/records/15300759?preview=1",
        "doi": "https://doi.org/10.5281/zenodo.15300759",
        "self_doi": "https://doi.org/10.5281/zenodo.15300759",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15300759",
        "parent": "https://zenodo.org/api/records/15300758",
        "parent_html": "https://zenodo.org/records/15300758",
        "parent_doi": "https://doi.org/10.5281/zenodo.15300758",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15300758",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:15300759/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:15300759/sequence/default",
        "files": "https://zenodo.org/api/records/15300759/files",
        "media_files": "https://zenodo.org/api/records/15300759/media-files",
        "archive": "https://zenodo.org/api/records/15300759/files-archive",
        "archive_media": "https://zenodo.org/api/records/15300759/media-files-archive",
        "latest": "https://zenodo.org/api/records/15300759/versions/latest",
        "latest_html": "https://zenodo.org/records/15300759/latest",
        "versions": "https://zenodo.org/api/records/15300759/versions",
        "draft": "https://zenodo.org/api/records/15300759/draft",
        "reserve_doi": "https://zenodo.org/api/records/15300759/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/15300759/access/links",
        "access_grants": "https://zenodo.org/api/records/15300759/access/grants",
        "access_users": "https://zenodo.org/api/records/15300759/access/users",
        "access_request": "https://zenodo.org/api/records/15300759/access/request",
        "access": "https://zenodo.org/api/records/15300759/access",
        "communities": "https://zenodo.org/api/records/15300759/communities",
        "communities-suggestions": "https://zenodo.org/api/records/15300759/communities-suggestions",
        "requests": "https://zenodo.org/api/records/15300759/requests"
      },
      "updated": "2025-04-29T05:58:30.606760+00:00",
      "recid": "15300759",
      "revision": 4,
      "files": [
        {
          "id": "1d865822-8ba2-4b95-8dff-8301b9c94094",
          "key": "Global Non-Small-Cell Lung Cancer Drug Market.csv",
          "size": 686,
          "checksum": "md5:c8d6c73cf75fca23a0fbca22708af0a2",
          "links": {
            "self": "https://zenodo.org/api/records/15300759/files/Global Non-Small-Cell Lung Cancer Drug Market.csv/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "1180855"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 1,
        "unique_downloads": 1,
        "views": 1,
        "unique_views": 1,
        "version_downloads": 1,
        "version_unique_downloads": 1,
        "version_unique_views": 1,
        "version_views": 1
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-04-29T03:27:02.845243+00:00",
      "modified": "2025-04-29T03:27:03.052160+00:00",
      "id": 15294349,
      "conceptrecid": "15294348",
      "doi": "10.63096/medtigo3061222",
      "doi_url": "https://doi.org/10.63096/medtigo3061222",
      "metadata": {
        "title": "Role of Marine Natural Products in Combating SARS-CoV-2 and COVID-19",
        "doi": "10.63096/medtigo3061222",
        "publication_date": "2025-04-28",
        "description": "<p><span lang=\"EN-US\">From the inception of coronavirus disease 2019 (COVID-19) pandemic has plague-ridden several millions of human beings across the world in a short time interval and force the world to experience extraordinary economic and life loss. Consequently, it is compulsory to find operational cures against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), because it is the biological cause of COVID-19. Synthetic medicines, such as hydroxychloroquine, have acquired large attention. Though, the effectiveness of this drug is still under examination, and moreover, certain severe consequences are a source of distress. This underlines the urgency for treatment alternatives, which can be in cooperation with efficiency and safety. Until now, there are no specifically recognized drugs to fight this virus and the procedure for new drug development is prolonged. Most encouraging candidates, which emerged as prospective frontrunners, were abandoned later while still in the phase of clinical examinations. With no convinced therapeutics in the prospect, natural products are in wide use randomly as anti-viral remedy and immune promoters. For centuries it has been well-known that most marine natural products have effective anti-viral properties with SARS-CoV-2. It has been exposed that natural products show inhibitory activities on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and SARS-CoV infections. </span></p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Magaji, Amayindi",
            "affiliation": null
          },
          {
            "name": "Jimoh, Onimisi Yakubu",
            "affiliation": null
          },
          {
            "name": "Joel, Yakubu",
            "affiliation": null
          },
          {
            "name": "Rubiyamisumma, Dorcas Kaduna",
            "affiliation": null
          }
        ],
        "contributors": [
          {
            "name": "medtigo",
            "affiliation": null,
            "type": "HostingInstitution"
          }
        ],
        "keywords": [
          "Severe acute respiratory syndrome, Middle east respiratory syndrome coronavirus, Coronavirus disease, Clinical examination, Anti-viral properties."
        ],
        "related_identifiers": [
          {
            "identifier": "3065-4661",
            "relation": "isPublishedIn",
            "resource_type": "publication-journal",
            "scheme": "issn"
          }
        ],
        "dates": [
          {
            "type": "accepted"
          }
        ],
        "references": [
          "1.\tRiou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020.\u202fEuro Surveill. 2020;25(4):2000058. doi:10.2807/1560-7917.ES.2020.25.4.2000058  PubMed | Crossref | Google Scholar",
          "2.\tNagahawatta DP, Liyanage NM, Jayawardena TU, et al. Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects. Mar Life Sci Technol. 2024;6(2):280-297. doi:10.1007/s42995-023-00215-9 PubMed | Crossref | Google Scholar",
          "3.\tSingh R, Chauhan N, Kuddus M. Exploring the therapeutic potential of marine-derived bioactive compounds against COVID-19. Environ Sci Pollut Res Int. 2021;28(38):52798-52809. doi:10.1007/s11356-021-16104-6 PubMed | Crossref | Google Scholar",
          "4.\tGuarner J. Three Emerging Coronaviruses in Two Decades.\u202fAm J Clin Pathol. 2020;153(4):420-421. doi:10.1093/ajcp/aqaa029  PubMed | Crossref | Google Scholar",
          "5.\tParker EPK, Shrotri M, Kampmann B. Keeping track of the SARS-CoV-2 vaccine pipeline.\u202fNat Rev Immunol. 2020;20(11):650. doi:10.1038/s41577-020-00455-1  PubMed | Crossref | Google Scholar",
          "6.\tPlante JA, Liu Y, Liu J, et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021;592(7852):116-121. doi:10.1038/s41586-020-2895-3 PubMed | Crossref | Google Scholar",
          "7.\tTegally H, Wilkinson E, Giovanetti M, et al. Detection of a SARS-CoV-2 variant of concern in South Africa.\u202fNature. 2021;592(7854):438-443. doi:10.1038/s41586-021-03402-9 PubMed | Crossref | Google Scholar",
          "8.\tHoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.\u202fCell. 2020;181(2):271-280.e8. doi:10.1016/j.cell.2020.02.052 PubMed | Crossref | Google Scholar",
          "9.\tPillaiyar T, Manickam M, Namasivayam V, Hayashi Y, Jung SH. An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.\u202fJ Med Chem. 2016;59(14):6595-6628. doi:10.1021/acs.jmedchem.5b01461 PubMed | Crossref | Google Scholar",
          "10.\tMunster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment.\u202fN Engl J Med. 2020;382(8):692-694. doi:10.1056/NEJMp2000929 PubMed | Crossref | Google Scholar",
          "11.\tMayer AM, Rodr\u00edguez AD, Berlinck RG, Fusetani N. Marine pharmacology in 2007-8: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action.\u202fComp Biochem Physiol C Toxicol Pharmacol. 2011;153(2):191-222. doi:10.1016/j.cbpc.2010.08.008 PubMed | Crossref | Google Scholar",
          "12.\tAtanasov AG, Waltenberger B, Pferschy-Wenzig EM, et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review.\u202fBiotechnol Adv. 2015;33(8):1582-1614. doi:10.1016/j.biotechadv.2015.08.001 PubMed | Crossref | Google Scholar",
          "13.\tHarvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era.\u202fNat Rev Drug Discov. 2015;14(2):111-129. doi:10.1038/nrd4510 PubMed | Crossref | Google Scholar",
          "14.\tTintore M, Vidal-Jordana A, Sastre-Garriga J. Treatment of multiple sclerosis success from bench to bedside.\u202fNat Rev Neurol. 2019;15(1):53-58. doi:10.1038/s41582-018-0082-z PubMed | Crossref | Google Scholar",
          "15.\tWaltenberger B, Mocan A, \u0160mejkal K, Heiss EH, Atanasov AG. Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders.\u202fMolecules. 2016;21(6):807. doi:10.3390/molecules21060807 PubMed | Crossref | Google Scholar",
          "16.\tDhand R, Li J. Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2.\u202fAm J Respir Crit Care Med. 2020;202(5):651-659. doi:10.1164/rccm.202004-1263PP PubMed | Crossref | Google Scholar",
          "17.\tGeahchan S, Ehrlich H, Rahman MA. The Anti-Viral Applications of Marine Resources for COVID-19 Treatment: An Overview. Mar Drugs. 2021;19(8):409. doi:10.3390/md19080409 PubMed | Crossref | Google Scholar",
          "18.\tGuo ZD, Wang ZY, Zhang SF, et al. Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020.\u202fEmerg Infect Dis. 2020;26(7):1583-1591. doi:10.3201/eid2607.200885 PubMed | Crossref | Google Scholar",
          "19.\tTran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review.\u202fPLoS One. 2012;7(4):e35797. doi:10.1371/journal.pone.0035797 PubMed | Crossref | Google Scholar",
          "20.\tLai Y, Yan Y, Liao S, et al. 3D-quantitative structure-activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase.\u202fArch Pharm Res. 2020;43(5):489-502. doi:10.1007/s12272-020-01230-5 PubMed | Crossref | Google Scholar",
          "21.\tUzair B, Mahmood Z, Tabassum S. Antiviral activity of natural products extracted from marine organisms. Bioimpacts. 2011;1(4):203-211. doi:10.5681/bi.2011.029 PubMed | Crossref | Google Scholar",
          "22.\tLi Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.\u202fN Engl J Med. 2020;382(13):1199-1207. doi:10.1056/NEJMoa2001316 PubMed | Crossref | Google Scholar",
          "23.\tDevi VK, Jain N, Valli KS. Importance of novel drug delivery systems in herbal medicines.\u202fPharmacogn Rev. 2010;4(7):27-31. doi:10.4103/0973-7847.65322 PubMed | Crossref | Google Scholar",
          "24.\tRampogu S, Gajula RG, Lee G, Kim MO, Lee KW. Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape. Comput Biol Med. 2021;135:104525. doi:10.1016/j.compbiomed.2021.104525 PubMed | Crossref | Google Scholar",
          "25.\tRahman MM, Islam MR, Shohag S, et al. Multifaceted role of natural sources for COVID-19 pandemic as marine drugs. Environ Sci Pollut Res Int. 2022;29(31):46527-46550. doi:10.1007/s11356-022-20328-5 PubMed | Crossref | Google Scholar",
          "26.\tOkechukwu QN, Adepoju FO, Kanwugu ON, et al. Marine-Derived Bioactive Metabolites as a Potential Therapeutic Intervention in Managing Viral Diseases: Insights from the SARS-CoV-2 In Silico and Pre-Clinical Studies. Pharmaceuticals (Basel). 2024;17(3):328. doi:10.3390/ph17030328 PubMed | Crossref | Google Scholar",
          "27.\tMishra P, Sohrab S, Mishra SK. A review on the phytochemical and pharmacological properties of\u202fHyptis suaveolens\u202f(L.) Poit.\u202fFutur J Pharm Sci. 2021;7(1):65. doi:10.1186/s43094-021-00219-1 PubMed | Crossref | Google Scholar",
          "28.\tLayqah LA, Eissa S. An electrochemical immunosensor for the corona virus associated with the Middle East respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes.\u202fMikrochim Acta. 2019;186(4):224. doi:10.1007/s00604-019-3345-5 PubMed | Crossref | Google Scholar",
          "29.\tPalmieri V, Papi M. Can graphene take part in the fight against COVID-19?.\u202fNano Today. 2020;33:100883. doi:10.1016/j.nantod.2020.100883 PubMed | Crossref | Google Scholar",
          "30.\tDacrory S. Antimicrobial Activity, DFT Calculations, and Molecular Docking of Dialdehyde Cellulose/Graphene Oxide Film Against Covid-19.\u202fJ Polym Environ. 2021;29(7):2248-2260. doi:10.1007/s10924-020-02039-5 PubMed | Crossref | Google Scholar",
          "31.\tLobo-Galo N, G\u00e1lvez-Ru\u00edz JC, Balderrama-Carmona AP, Silva-Beltr\u00e1n NP, Ruiz-Bustos E. Recent biotechnological advances as potential intervention strategies against COVID-19.\u202f3 Biotech. 2021;11(2):41. doi:10.1007/s13205-020-02619-1 PubMed | Crossref | Google Scholar",
          "32.\tHashemi B, Akram FA, Amirazad H, et al. Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients.\u202fJ Drug Deliv Sci Technol. 2022;67:102967. doi:10.1016/j.jddst.2021.102967 PubMed | Crossref | Google Scholar",
          "33.\tJia Q, Fu J, Liang P, et al. Investigating interactions between chloroquine/hydroxychloroquine and their single enantiomers and angiotensin-converting enzyme 2 by a cell membrane chromatography method.\u202fJ Sep Sci. 2022;45(2):456-467. doi:10.1002/jssc.202100570 PubMed | Crossref | Google Scholar",
          "34.\tTang WF, Tsai HP, Chang YH, et al. Perilla (Perilla frutescens) leaf extract inhibits SARS-CoV-2 via direct virus inactivation.\u202fBiomed J. 2021;44(3):293-303. doi:10.1016/j.bj.2021.01.005 PubMed | Crossref | Google Scholar",
          "35.\tYi M, Lin S, Zhang B, Jin H, Ding L. Antiviral potential of natural products from marine microbes. Eur J Med Chem. 2020;207:112790. doi:10.1016/j.ejmech.2020.112790 PubMed | Crossref | Google Scholar",
          "36.\tMossaad E, Furuyama W, Enomoto M, Kawai S, Mikoshiba K, Kawazu S. Simultaneous administration of 2-aminoethyl diphenylborinate and chloroquine reverses chloroquine resistance in malaria parasites.\u202fAntimicrob Agents Chemother. 2015;59(5):2890-2892. doi:10.1128/AAC.04805-14 PubMed | Crossref | Google Scholar",
          "37.\tAlobaida A, Abouzied AS, Younes KM, Alzhrani RM, Alsaab HO, Huwaimel B. Analyzing energetics and dynamics of hepatitis C virus polymerase interactions with marine bacterial compounds: a computational study. Mol Divers. 2025;29(2):1245-1260. doi:10.1007/s11030-024-10904-x PubMed | Crossref | Google Scholar",
          "38.\tRoy A, Das R, Roy D, et al. Encapsulated hydroxychloroquine and chloroquine into cyclic oligosaccharides are the potential therapeutics for COVID-19: insights from first-principles calculations.\u202fJ Mol Struct. 2022;1247:131371. doi:10.1016/j.molstruc.2021.131371 PubMed | Crossref | Google Scholar",
          "39.\tChen Z, Liu A, Cheng Y, et al. Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study.\u202fBMC Infect Dis. 2021;21(1):805. doi:10.1186/s12879-021-06477-x PubMed | Crossref | Google Scholar",
          "40.\tYao Q, Xing Y, Ma J, Wang C, Zang J, Zhao G. Binding of Chloroquine to Whey Protein Relieves Its Cytotoxicity while Enhancing Its Uptake by Cells.\u202fJ Agric Food Chem. 2021;69(36):10669-10677. doi:10.1021/acs.jafc.1c04140 PubMed | Crossref | Google Scholar",
          "41.\tZazo H, Colino CI, Lanao JM. Current applications of nanoparticles in infectious diseases. J Control Release. 2016;224:86-102. doi:10.1016/j.jconrel.2016.01.008 PubMed | Crossref | Google Scholar",
          "42.\tGagliardi M. Biomimetic and bioinspired nanoparticles for targeted drug delivery.\u202fTher Deliv. 2017;8(5):289-299. doi:10.4155/tde-2017-0013 PubMed | Crossref | Google Scholar",
          "43.\tChen L, Liang J. An overview of functional nanoparticles as novel emerging antiviral therapeutic agents.\u202fMater Sci Eng C Mater Biol Appl. 2020;112:110924. doi:10.1016/j.msec.2020.110924 PubMed | Crossref | Google Scholar",
          "44.\tGurunathan S, Qasim M, Choi Y, et al. Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?.\u202fNanomaterials (Basel). 2020;10(9):1645. doi:10.3390/nano10091645 PubMed | Crossref | Google Scholar",
          "45.\tSathasivam R, Radhakrishnan R, Hashem A, Abd Allah EF. Microalgae metabolites: A rich source for food and medicine.\u202fSaudi J Biol Sci. 2019;26(4):709-722. doi:10.1016/j.sjbs.2017.11.003 PubMed | Crossref | Google Scholar",
          "46.\tLee C. Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application.\u202fMar Drugs. 2019;17(10):567. doi:10.3390/md17100567 PubMed | Crossref | Google Scholar",
          "47.\tLevendosky K, Mizenina O, Martinelli E, et al. Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.\u202fAntimicrob Agents Chemother. 2015;59(12):7290-7298. doi:10.1128/AAC.01816-15 PubMed | Crossref | Google Scholar",
          "48.\tO'Keefe BR, Giomarelli B, Barnard DL, et al. Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae.\u202fJ Virol. 2010;84(5):2511-2521. doi:10.1128/JVI.02322-09 PubMed | Crossref | Google Scholar",
          "49.\tMorokutti-Kurz M, Fr\u00f6ba M, Graf P, et al. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.\u202fPLoS One. 2021;16(2):e0237480. doi:10.1371/journal.pone.0237480 PubMed | Crossref | Google Scholar",
          "50.\tMoulaei T, Alexandre KB, Shenoy SR, et al. Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus.\u202fRetrovirology. 2015;12:6. doi:10.1186/s12977-014-0127-3 PubMed | Crossref | Google Scholar",
          "51.\tLee C. Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application.\u202fMar Drugs. 2019;17(10):567. doi:10.3390/md17100567 PubMed | Crossref | Google Scholar",
          "52.\tO'Keefe BR, Vojdani F, Buffa V, et al. Scaleable manufacture of HIV-1 entryinhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.\u202fProc Natl Acad Sci U S A. 2009;106(15):6099-6104. doi:10.1073/pnas.0901506106 PubMed | Crossref | Google Scholar",
          "53.\tLusvarghi S, Bewley CA. Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential.\u202fViruses. 2016;8(10):296. doi:10.3390/v8100296 PubMed | Crossref | Google Scholar",
          "54.\tBuck CB, Thompson CD, Roberts JN, M\u00fcller M, Lowy DR, Schiller JT. Carrageenan is a potent inhibitor of papillomavirus infection.\u202fPLoS Pathog. 2006;2(7):e69. doi:10.1371/journal.ppat.0020069 PubMed | Crossref | Google Scholar",
          "55.\tRodrigues Felix C, Gupta R, Geden S, et al. Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products. Antimicrob Agents Chemother. 2017;61(8):e00743-17. doi:10.1128/AAC.00743-17 PubMed | Crossref | Google Scholar",
          "56.\tFriedland BA, Hoesley CJ, Plagianos M, et al. First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics.\u202fJ Acquir Immune Defic Syndr. 2016;73(5):489-496. doi:10.1097/QAI.0000000000001136 PubMed | Crossref | Google Scholar",
          "57.\tHebar A, Koller C, Seifert JM, et al. Non-clinical safety evaluation of intranasal iota-carrageenan.\u202fPLoS One. 2015;10(4):e0122911. doi:10.1371/journal.pone.0122911 PubMed | Crossref | Google Scholar",
          "58.\tU.S. Food and Drug Administration (FDA). CFR - Code of Federal Regulations Title 21. 2024. CFR - Code of Federal Regulations Title 21",
          "59.\tYasuhara-Bell J, Lu Y. Marine compounds and their antiviral activities. Antiviral Res. 2010;86(3):231-240. doi:10.1016/j.antiviral.2010.03.009 PubMed | Crossref | Google Scholar",
          "60.\tLi YX, Wijesekara I, Li Y, Kim SK. Phlorotannins as bioactive agents from brown algae. Process Biochem. 2011;46(12):2219\u20132224. doi:10.1016/j.procbio.2011.09.015 Crossref | Google Scholar",
          "61.\tHeo SJ, Ko SC, Cha SH, et al. Effect of phlorotannins isolated from Ecklonia cava on melanogenesis and their protective effect against photo-oxidative stress induced by UV-B radiation.\u202fToxicol In Vitro. 2009;23(6):1123-1130. doi:10.1016/j.tiv.2009.05.013 PubMed | Crossref | Google Scholar",
          "62.\tYoon NY, Eom TK, Kim MM, Kim SK. Inhibitory effect of phlorotannins isolated from Ecklonia cava on mushroom tyrosinase activity and melanin formation in mouse B16F10 melanoma cells.\u202fJ Agric Food Chem. 2009;57(10):4124-4129. doi:10.1021/jf900006f PubMed | Crossref | Google Scholar",
          "63.\tKong CS, Kim JA, Yoon NY, Kim SK. Induction of apoptosis by phloroglucinol derivative from Ecklonia Cava in MCF-7 human breast cancer cells.\u202fFood Chem Toxicol. 2009;47(7):1653-1658. doi:10.1016/j.fct.2009.04.013 PubMed | Crossref | Google Scholar",
          "64.\tArtan M, Li Y, Karadeniz F, Lee SH, Kim MM, Kim SK. Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.\u202fBioorg Med Chem. 2008;16(17):7921-7926. doi:10.1016/j.bmc.2008.07.078 PubMed | Crossref | Google Scholar",
          "65.\tZhang R, Kang KA, Piao MJ, et al. Eckol protects V79-4 lung fibroblast cells against gamma-ray radiation-induced apoptosis via the scavenging of reactive oxygen species and inhibiting of the c-Jun NH(2)-terminal kinase pathway.\u202fEur J Pharmacol. 2008;591(1-3):114-123. doi:10.1016/j.ejphar.2008.06.086 PubMed | Crossref | Google Scholar",
          "66.\tMyung CS, Shin HC, Bao HY, Yeo SJ, Lee BH, Kang JS. Improvement of memory by dieckol and phlorofucofuroeckol in ethanol-treated mice: possible involvement of the inhibition of acetylcholinesterase.\u202fArch Pharm Res. 2005;28(6):691-698. doi:10.1007/BF02969360 PubMed | Crossref | Google Scholar",
          "67.\tKhan MT, Ali A, Wang Q, et al. Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2-a molecular dynamic study.\u202fJ Biomol Struct Dyn. 2021;39(10):3627-3637. doi:10.1080/07391102.2020.1769733 PubMed | Crossref | Google Scholar",
          "68.\tPark JY, Ko JA, Kim DW, et al. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV.\u202fJ Enzyme Inhib Med Chem. 2016;31(1):23-30. doi:10.3109/14756366.2014.1003215 PubMed | Crossref | Google Scholar",
          "69.\tHirata T, Tanaka M, Ooike M, Tsunomura T, Sakaguchi M. Antioxidant activities of phycocyanobilin prepared from Spirulina platensis. J Appl Phycol. 2000;12(5):435-439. doi:10.1023/A:1008175217194 Crossref | Google Scholar",
          "70.\tPendyala B, Patras A. In silico Screening of Food Bioactive Compounds to Predict Potential Inhibitors of COVID-19 Main protease (Mpro) and RNA-dependent RNA polymerase (RdRp). ChemRxiv. 2020. doi:10.26434/chemrxiv.12051927.v2\u202f  Crossref | Google Scholar",
          "71.\tSun QL, Li Y, Ni LQ, et al. Structural characterization and antiviral activity of two fucoidans from the brown algae Sargassum henslowianum.\u202fCarbohydr Polym. 2020;229:115487. doi:10.1016/j.carbpol.2019.115487 PubMed | Crossref | Google Scholar",
          "72.\tKwon PS, Oh H, Kwon SJ, et al. Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro.\u202fCell Discov. 2020;6(1):50. doi:10.1038/s41421-020-00192-8 PubMed | Crossref | Google Scholar",
          "73.\tVijayaraj R, Altaff K, Rosita AS, Ramadevi S, Revathy J. Bioactive compounds from marine resources against novel corona virus (2019-nCoV):\u202fin silico\u202fstudy for corona viral drug.\u202fNat Prod Res. 2021;35(23):5525-5529. doi:10.1080/14786419.2020.1791115 PubMed | Crossref | Google Scholar",
          "74.\tZakaryan H, Arabyan E, Oo A, Zandi K. Flavonoids: promising natural compounds against viral infections.\u202fArch Virol. 2017;162(9):2539-2551. doi:10.1007/s00705-017-3417-y PubMed | Crossref | Google Scholar",
          "75.\tKhan MT, Ali A, Wang Q, et al. Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2-a molecular dynamic study. J Biomol Struct Dyn. 2021;39(10):3627-3637. doi:10.1080/07391102.2020.1769733 PubMed | Crossref | Google Scholar",
          "76.\tLetko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.\u202fNat Microbiol. 2020;5(4):562-569. doi:10.1038/s41564-020-0688-y PubMed | Crossref | Google Scholar"
        ],
        "language": "eng",
        "resource_type": {
          "title": "Journal article",
          "type": "publication",
          "subtype": "article"
        },
        "journal": {
          "issue": "2",
          "pages": "e3061222",
          "title": "medtigo Journal of Pharmacology",
          "volume": "2"
        },
        "alternate_identifiers": [
          {
            "identifier": "https://journal.medtigo.com/role-of-marine-natural-products-in-combating-sars-cov-2-and-covid-19/?article_type=journal-of-pharmacology"
          }
        ],
        "license": {
          "id": "cc-by-4.0"
        },
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "15294348"
              }
            }
          ]
        }
      },
      "title": "Role of Marine Natural Products in Combating SARS-CoV-2 and COVID-19",
      "links": {
        "self": "https://zenodo.org/api/records/15294349",
        "self_html": "https://zenodo.org/records/15294349",
        "preview_html": "https://zenodo.org/records/15294349?preview=1",
        "doi": "https://doi.org/10.63096/medtigo3061222",
        "self_doi": "https://doi.org/10.63096/medtigo3061222",
        "self_doi_html": "https://zenodo.org/doi/10.63096/medtigo3061222",
        "parent": "https://zenodo.org/api/records/15294348",
        "parent_html": "https://zenodo.org/records/15294348",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:15294349/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:15294349/sequence/default",
        "files": "https://zenodo.org/api/records/15294349/files",
        "media_files": "https://zenodo.org/api/records/15294349/media-files",
        "archive": "https://zenodo.org/api/records/15294349/files-archive",
        "archive_media": "https://zenodo.org/api/records/15294349/media-files-archive",
        "latest": "https://zenodo.org/api/records/15294349/versions/latest",
        "latest_html": "https://zenodo.org/records/15294349/latest",
        "versions": "https://zenodo.org/api/records/15294349/versions",
        "draft": "https://zenodo.org/api/records/15294349/draft",
        "reserve_doi": "https://zenodo.org/api/records/15294349/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/15294349/access/links",
        "access_grants": "https://zenodo.org/api/records/15294349/access/grants",
        "access_users": "https://zenodo.org/api/records/15294349/access/users",
        "access_request": "https://zenodo.org/api/records/15294349/access/request",
        "access": "https://zenodo.org/api/records/15294349/access",
        "communities": "https://zenodo.org/api/records/15294349/communities",
        "communities-suggestions": "https://zenodo.org/api/records/15294349/communities-suggestions",
        "requests": "https://zenodo.org/api/records/15294349/requests"
      },
      "updated": "2025-04-29T03:27:03.052160+00:00",
      "recid": "15294349",
      "revision": 4,
      "files": [
        {
          "id": "4ce68dd9-3a16-4381-8393-787db0d02b58",
          "key": "413_Final.docx",
          "size": 158505,
          "checksum": "md5:1db9594917ed3a111bc1bff51bcff296",
          "links": {
            "self": "https://zenodo.org/api/records/15294349/files/413_Final.docx/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "1032827"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 0,
        "unique_downloads": 0,
        "views": 1,
        "unique_views": 1,
        "version_downloads": 0,
        "version_unique_downloads": 0,
        "version_unique_views": 1,
        "version_views": 1
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-04-28T17:19:17.979313+00:00",
      "modified": "2025-04-28T17:19:18.238378+00:00",
      "id": 15298475,
      "conceptrecid": "15298431",
      "doi": "10.5281/zenodo.15298475",
      "conceptdoi": "10.5281/zenodo.15298431",
      "doi_url": "https://doi.org/10.5281/zenodo.15298475",
      "metadata": {
        "title": "Security GUI",
        "doi": "10.5281/zenodo.15298475",
        "publication_date": "2025-04-26",
        "description": "<p>Vulnerability scanning is critical for modern cybersecurity, helping protect systems and networks from evolving threats. This paper presents an integrated vulnerability scanning platform that combines three tools: a system-level scanner, a web application scanner, and a network-level scanner, all within a unified web interface. The platform&rsquo;s modular architecture allows each tool to operate independently while sharing data like vulnerability signatures, scan results, and remediation rec- ommendations. This approach streamlines security assessments, provides a comprehensive view of potential weaknesses, and improves scan efficiency. The paper discusses the system&rsquo;s de- sign, integration, and operational details, focusing on microservices, containerization, and automated database updates. It also evaluates the platform&rsquo;s performance, accuracy, and potential improvements, offering a more effective way for security teams to mitigate cyberattack risks.</p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Chinmay Desai",
            "affiliation": null
          },
          {
            "name": "Prashant Hage",
            "affiliation": null
          },
          {
            "name": "Prajwal Vannewar",
            "affiliation": null
          },
          {
            "name": "Prof. Swati Shinde",
            "affiliation": null
          }
        ],
        "resource_type": {
          "title": "Journal article",
          "type": "publication",
          "subtype": "article"
        },
        "journal": {
          "issue": "2",
          "pages": "1 - 8",
          "title": "INTERNATIONAL JOURNAL OF INNOVATIVE RESEARCH AND CREATIVE TECHNOLOGY",
          "volume": "11"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "relations": {
          "version": [
            {
              "index": 1,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "15298431"
              }
            }
          ]
        }
      },
      "title": "Security GUI",
      "links": {
        "self": "https://zenodo.org/api/records/15298475",
        "self_html": "https://zenodo.org/records/15298475",
        "preview_html": "https://zenodo.org/records/15298475?preview=1",
        "doi": "https://doi.org/10.5281/zenodo.15298475",
        "self_doi": "https://doi.org/10.5281/zenodo.15298475",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15298475",
        "parent": "https://zenodo.org/api/records/15298431",
        "parent_html": "https://zenodo.org/records/15298431",
        "parent_doi": "https://doi.org/10.5281/zenodo.15298431",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.15298431",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:15298475/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:15298475/sequence/default",
        "files": "https://zenodo.org/api/records/15298475/files",
        "media_files": "https://zenodo.org/api/records/15298475/media-files",
        "thumbnails": {
          "10": "https://zenodo.org/api/iiif/record:15298475:2504074%20IJIRCT%2026%20April%2C%202025.pdf/full/^10,/0/default.jpg",
          "50": "https://zenodo.org/api/iiif/record:15298475:2504074%20IJIRCT%2026%20April%2C%202025.pdf/full/^50,/0/default.jpg",
          "100": "https://zenodo.org/api/iiif/record:15298475:2504074%20IJIRCT%2026%20April%2C%202025.pdf/full/^100,/0/default.jpg",
          "250": "https://zenodo.org/api/iiif/record:15298475:2504074%20IJIRCT%2026%20April%2C%202025.pdf/full/^250,/0/default.jpg",
          "750": "https://zenodo.org/api/iiif/record:15298475:2504074%20IJIRCT%2026%20April%2C%202025.pdf/full/^750,/0/default.jpg",
          "1200": "https://zenodo.org/api/iiif/record:15298475:2504074%20IJIRCT%2026%20April%2C%202025.pdf/full/^1200,/0/default.jpg"
        },
        "archive": "https://zenodo.org/api/records/15298475/files-archive",
        "archive_media": "https://zenodo.org/api/records/15298475/media-files-archive",
        "latest": "https://zenodo.org/api/records/15298475/versions/latest",
        "latest_html": "https://zenodo.org/records/15298475/latest",
        "versions": "https://zenodo.org/api/records/15298475/versions",
        "draft": "https://zenodo.org/api/records/15298475/draft",
        "reserve_doi": "https://zenodo.org/api/records/15298475/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/15298475/access/links",
        "access_grants": "https://zenodo.org/api/records/15298475/access/grants",
        "access_users": "https://zenodo.org/api/records/15298475/access/users",
        "access_request": "https://zenodo.org/api/records/15298475/access/request",
        "access": "https://zenodo.org/api/records/15298475/access",
        "communities": "https://zenodo.org/api/records/15298475/communities",
        "communities-suggestions": "https://zenodo.org/api/records/15298475/communities-suggestions",
        "requests": "https://zenodo.org/api/records/15298475/requests"
      },
      "updated": "2025-04-28T17:19:18.238378+00:00",
      "recid": "15298475",
      "revision": 4,
      "files": [
        {
          "id": "8387050c-62ec-4c88-8292-9c6ba2c79e00",
          "key": "2504074 IJIRCT 26 April, 2025.pdf",
          "size": 453014,
          "checksum": "md5:d21cd3906d63d7eec9aba43f4c78c82c",
          "links": {
            "self": "https://zenodo.org/api/records/15298475/files/2504074 IJIRCT 26 April, 2025.pdf/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "393164"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 8,
        "unique_downloads": 3,
        "views": 8,
        "unique_views": 3,
        "version_downloads": 2,
        "version_unique_downloads": 1,
        "version_unique_views": 1,
        "version_views": 2
      },
      "state": "done",
      "submitted": true
    },
    {
      "created": "2025-04-28T15:57:40.146201+00:00",
      "modified": "2025-04-28T15:57:40.409860+00:00",
      "id": 14826348,
      "conceptrecid": "14826347",
      "doi": "10.5281/zenodo.14826348",
      "conceptdoi": "10.5281/zenodo.14826347",
      "doi_url": "https://doi.org/10.5281/zenodo.14826348",
      "metadata": {
        "title": "NewsWords Data (Word Counts)",
        "doi": "10.5281/zenodo.14826348",
        "publication_date": "2025-03-01",
        "description": "<h1>NewsWords</h1>\n<h2>Word Counts from the British Library's Digitised Newspaper Collections</h2>\n<h3>Description</h3>\n<p>The NewsWords dataset contains word count data derived from newspapers published in Britain during the \"long\" nineteenth century (1780-1920) and digitised as of 2025. These frequencies are computed from the British Library's collection.&nbsp;</p>\n<p><br>The tar file contains 269,179 JSON files. Each file captures the word counts for one month for one newspaper title. The filenames are structured as follows: \"{newspaper_id}_{year}_{month}.json\", e.g. \"0003281_1896_07.json\".&nbsp;</p>\n<p>Each file consists of a dictionary mapping words to their frequencies, e.g. {\"newspaper\": 19, \"transmission\": 11}.</p>\n<p>Together, the word counts represent a corpus of 120 billion tokens based on a vocabulary of 200k unique words appearing more than five times. Please follow&nbsp;<a href=\"https://github.com/Living-with-machines/newswords/blob/readme/figures/countsbydecade.png\" target=\"_blank\" rel=\"noopener\">this link</a> to view a bar chart that breaks down the word counts by decade.</p>\n<p>The newspaper_id corresponds with NLP ids, which are documented in the British Library newspaper catalogue:</p>\n<p>&gt; Ryan, Yann, and Luke McKernan. 2021. &ldquo;Converting the British Library&rsquo;s Catalogue of British and Irish Newspapers into a Public Domain Dataset: Processes and Applications&rdquo;. *Journal of Open Humanities Data* 7 (0): 1. https://doi.org/10.5334/johd.23.</p>\n<p>Complete metadata for this newspaper collection is available in another open dataset:</p>\n<p>&gt; Westerling, Kalle, Timothy Hobson, Kaspar Beelen, Nilo Pedrazzini, Daniel Wilson, and Katherine McDonough. &ldquo;Lwmdb Data&rdquo;. *Zenodo*, December 11, 2024. https://doi.org/10.5281/zenodo.14389180.</p>\n<h3>Code</h3>\n<p>The&nbsp;<a href=\"https://github.com/Living-with-machines/newswords\">NewsWords Code GitHub </a><a href=\"https://github.com/Living-with-machines/newswords\" target=\"_blank\" rel=\"noopener\">repository&nbsp;</a>provides code for converting \"raw\" word counts to a more manageable sparse matrix format and contextualises these counts with additional newspaper metadata, e.g. information about price and politics. Further Information about how to use the code and query the NewsWords data is available in the GitHub README.&nbsp;</p>\n<p>To recreate these sparse matrices, please follow the instructions in \"Create_sparse_matrices.ipynb\"</p>\n<h3>Limitations</h3>\n<p>These word counts are derived from the digitised press, containing billions of words, spanning multiple decades. However large, these data constitute around ##% of the number of newspaper titles that circulated in Great Britain. In our paper \"Whose News? Critical methods for assessing bias in large historical datasets\" (under review) we have tackled the issue of representativeness, and point out that these exhibit some partisan bias&mdash;in the sense that they overrepresent conservative and liberal newspaper titles&mdash;which varies over the 19th century.&nbsp;</p>\n<p>&gt; \"Whose News? Critical methods for assessing bias in<br>large historical datasets\" (under review)</p>\n<p>For more information about the method and data see also:</p>\n<p>&gt; Beelen, Kaspar, Jon Lawrence, Daniel C Wilson, and David Beavan, 2023. 'Bias and representativeness in digitized newspaper collections: Introducing the environmental scan.' *Digital Scholarship in the Humanities*, 38(1), pp.1-22.</p>",
        "access_right": "open",
        "creators": [
          {
            "name": "Beelen, Kaspar",
            "affiliation": "School of Advanced Study",
            "orcid": "0000-0001-7331-1174"
          }
        ],
        "contributors": [
          {
            "name": "Wilson, Daniel",
            "affiliation": "The Alan Turing Institute",
            "type": "Researcher",
            "orcid": "0000-0001-6886-775X"
          }
        ],
        "dates": [
          {
            "type": "created"
          }
        ],
        "language": "eng",
        "resource_type": {
          "title": "Dataset",
          "type": "dataset"
        },
        "license": {
          "id": "cc-by-4.0"
        },
        "grants": [
          {
            "code": "AH/S01179X/1",
            "internal_id": "0505m1554::AH/S01179X/1",
            "funder": {
              "name": "Arts and Humanities Research Council"
            },
            "title": "Living with Machines"
          }
        ],
        "relations": {
          "version": [
            {
              "index": 0,
              "is_last": true,
              "parent": {
                "pid_type": "recid",
                "pid_value": "14826347"
              }
            }
          ]
        }
      },
      "title": "NewsWords Data (Word Counts)",
      "links": {
        "self": "https://zenodo.org/api/records/14826348",
        "self_html": "https://zenodo.org/records/14826348",
        "preview_html": "https://zenodo.org/records/14826348?preview=1",
        "doi": "https://doi.org/10.5281/zenodo.14826348",
        "self_doi": "https://doi.org/10.5281/zenodo.14826348",
        "self_doi_html": "https://zenodo.org/doi/10.5281/zenodo.14826348",
        "parent": "https://zenodo.org/api/records/14826347",
        "parent_html": "https://zenodo.org/records/14826347",
        "parent_doi": "https://doi.org/10.5281/zenodo.14826347",
        "parent_doi_html": "https://zenodo.org/doi/10.5281/zenodo.14826347",
        "self_iiif_manifest": "https://zenodo.org/api/iiif/record:14826348/manifest",
        "self_iiif_sequence": "https://zenodo.org/api/iiif/record:14826348/sequence/default",
        "files": "https://zenodo.org/api/records/14826348/files",
        "media_files": "https://zenodo.org/api/records/14826348/media-files",
        "archive": "https://zenodo.org/api/records/14826348/files-archive",
        "archive_media": "https://zenodo.org/api/records/14826348/media-files-archive",
        "latest": "https://zenodo.org/api/records/14826348/versions/latest",
        "latest_html": "https://zenodo.org/records/14826348/latest",
        "versions": "https://zenodo.org/api/records/14826348/versions",
        "draft": "https://zenodo.org/api/records/14826348/draft",
        "reserve_doi": "https://zenodo.org/api/records/14826348/draft/pids/doi",
        "access_links": "https://zenodo.org/api/records/14826348/access/links",
        "access_grants": "https://zenodo.org/api/records/14826348/access/grants",
        "access_users": "https://zenodo.org/api/records/14826348/access/users",
        "access_request": "https://zenodo.org/api/records/14826348/access/request",
        "access": "https://zenodo.org/api/records/14826348/access",
        "communities": "https://zenodo.org/api/records/14826348/communities",
        "communities-suggestions": "https://zenodo.org/api/records/14826348/communities-suggestions",
        "requests": "https://zenodo.org/api/records/14826348/requests"
      },
      "updated": "2025-04-28T15:57:40.409860+00:00",
      "recid": "14826348",
      "revision": 4,
      "files": [
        {
          "id": "b529147b-7d58-4a7f-a199-db0440d8ba17",
          "key": "ngrams.tar.gz",
          "size": 75985095053,
          "checksum": "md5:468eca81cb68d6322598c88f737e9315",
          "links": {
            "self": "https://zenodo.org/api/records/14826348/files/ngrams.tar.gz/content"
          }
        }
      ],
      "swh": {},
      "owners": [
        {
          "id": "1018440"
        }
      ],
      "status": "published",
      "stats": {
        "downloads": 0,
        "unique_downloads": 0,
        "views": 1,
        "unique_views": 1,
        "version_downloads": 0,
        "version_unique_downloads": 0,
        "version_unique_views": 1,
        "version_views": 1
      },
      "state": "done",
      "submitted": true
    }
  ]
}